Our core activity is to identify, unlock and execute acquisitions, JVs, divestments and commercial alliances.
We advice on all phases of mid-sized cross-border transactions, including initiation of contacts, evaluation, negotiations, management of due diligence and final structuring. Rx Investment’s professionals have developed extensive experience in handling the unique issues that arise from cross-border, cross-cultural M&A. such as:
· Managing an M&A process in more than one language and across distant time zones.
· Divergent approaches to valuation.
· Managing due diligence in environments of sub-optimal transparency.
· "Coaching" counterparties who have limited M&A experience.
We are experienced working with Boards and management teams in both buy-side and sell-side mergers and acquisitions.
Our team has extensive experience providing financial advisory services associated with companies undergoing a ‘transforming’ strategic event, whether a sale, a combination, or a restructuring. Rx Investment have developed in-house proprietary research, methodologies and financial models useful in conducting valuations and professional appraisals for closely-held private companies and for public companies with inactively traded securities or for those with a high degree of controlling interests or restricted securities. Rx Investment’s team also has extensive experience with restructuring including the issuance of fairness opinions for transactions which are part of mergers and acquisitions.
Specific company restructuring situations we are experienced with include:
· Acquisitions.
· Divestures.
· Mergers.
· Buy-side and Sell-side Agreements.
· Recapitalizations.